Fundraising Fox
/Companies
Sign in

Theianova

4 employees on LinkedIn · 1 known investors

Find your way into Theianova

Sign up to see every warm intro you have to Theianova

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Theianova team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.

BiotechHealthtechMedical Devices

Founders & leadership

CG
Colin GreenChief Scientific Officer
CFCarissa Fonseca
Carissa FonsecaChief Executive OfficerCarissa Fonseca holds a PhD in cardiovascular MRI and has worked in medical affairs roles covering diagnostic imaging, anesthesia, and sedation, with experience spanning basic science through clinical trials and industry engagement with key opinion leaders across imaging modalities and anesthesia.
PAPriyanka Agarwal
Priyanka AgarwalDirector of Research & Operations, Formulation LeadPriyanka Agarwal is Director of Research & Operations and Formulation Lead at TheiaNova, a biotech developing corneal therapeutics. She brings pharmaceutical development experience from both industry and academic roles, with expertise in ocular drug delivery, formulation development, and controlled release systems.

Investors · 1

Frequently asked questions

What does Theianova do?
TheiaNova is developing a non-surgical therapy to induce remodeling of the cornea for patients with ectatic vision disorders such as keratoconus. The company, spun out of research at the University of Auckland's Department of Ophthalmology, is a biotech working to bring this corneal therapeutic agent to the clinic.
Who founded Theianova?
Theianova was founded by Colin Green.
Who are Theianova's investors?
Theianova's investors include Bridgewest Ventures.